PUBLIC COMPANY
save$EDSAEdesa Biotech, Inc.
$EDSAMarkham, Ontario, Canadaupdated 5mo ago
community read0 votes
pipeline
3
marketed
0
phase 3
2
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Preclinical2Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo
- phase3A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19
- phase2Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis
🐶 Hiring Signal
News
- Heron sells assets to CorMedix for $145M upfront; Faeth's stock tumblesPlus, news about Immunovant, Abeona Therapeutics, Ellodi Pharmaceuticals, Spruce Biosciences, Adrenyx Biosciences, Edesa Biotech, Kyorin Pharmaceutical, Charles River Laboratories, Frontage, Compas…endpoints · 7d ago
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that